Clinical trial
VitaFlow Liberty™ Transcatheter Aortic Valve System Post-market Clinical Follow-up Study
NCT06535659 is registered in ClinicalTrials.gov with Shanghai MicroPort CardioFlow Medtech Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- VitaFlow Liberty™ Transcatheter Aortic Valve System Post-market Clinical Follow-up Study
- Lead sponsor
- Shanghai MicroPort CardioFlow Medtech Co., Ltd.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 6, 2025
- Completion date
- June 30, 2033
- Enrollment
- 222 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.